ZimVie stock soars on EPS beat
WESTMINSTER — The stock price for ZimVie Inc. (Nasdaq: ZIMV), a medical technology company that manufactures devices for spinal surgery and oral reconstruction that was spun off last year from Zimmer Biomet Holdings Inc. (NYSE and SIX: ZBH), added more than 10% on Thursday after the company’s earnings per share outperformed Wall Street expectations.
Sales for the most-recent period were $202.9 million, a year-over-year decrease of 4.9%.
Net loss for the third quarter of 2023 was $5.1 million, compared with net income of $800,000 in the same period last year.
ZimVie’s adjusted earnings per…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Columbine Health Systems will host Dementia Week, a series of free events devoted to educating…
-
Nextera Healthcare LLC and ImagineMD have combined to form a single direct-primary-care organization for employer…
-
LOVELAND — The Stinging Nettle has taken up residence in downtown, filling a hole recently…
-
OneOncology, a physician-led national platform for independent oncology practices, has acquired United Urology Group, a…
